MedPath

Investigation on effects of sleep apnea syndrome (SAS) and its CPAP treatment on serum KL-6 level.

Not Applicable
Recruiting
Conditions
Sleep apnea syndrome
Registration Number
JPRN-UMIN000032953
Lead Sponsor
Kurume University school of medicine,Depertment of Neuropsychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with interstitial lung disease 2)Patients with hypoxemia (at awake resting SpO 2 <95%) 3)Patients with infectious pneumonia or drug pneumonia or advanced stage cancer or pulmonary tuberculosis or alveolar proteinosis. 4)Patients in a state of shock 5)Patients with disturbance of consciouness 6)Patients on a ventilator 7)patients who are cnsiderded unsuitable for the trial by attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The relationship between sleep apnea syndrome(SAS) and serum KL-6 level, and the effect of CPAP treatment on its level 6 months after the start of treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath